ANRO vs COLL: stock comparison and AI forecast
Alto Neuroscience, Inc. (ANRO) and Collegium Pharmaceutical, Inc (COLL) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ANRO Alto Neuroscience, Inc.
- Price
- $21.87 -9.1% · 6M
- Market Cap
- $858M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
COLL Collegium Pharmaceutical, Inc
- Price
- $25.16 -36.0% · 6M
- Market Cap
- $819M
- P/E Ratio
- 16.9x
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- ANRO and COLL have similar market capitalizations ($858M and $819M).
- Over the last six months ANRO returned -9.1% and COLL -36.0%.
- COLL carries 6.07 times debt per unit of equity, against 0.16 times for ANRO.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ANRO | COLL |
|---|---|---|
| Market Cap | $858M | $819M |
| P/E Ratio | – | 16.88x |
| P/B Ratio | 3.91x | 2.76x |
| EPS | $-2.19 | $1.49 |
| Book Value/Share | $5.59 | $9.11 |
| Revenue/Share | – | $25.04 |
| FCF/Share | $-1.75 | $10.33 |
Profitability & Margins
| Metric | ANRO | COLL |
|---|---|---|
| ROE | -38.4% | 12.9% |
| ROA | -33.2% | 1.8% |
| ROIC | -37.2% | 8.3% |
| Gross Margin | – | 59.0% |
| Operating Margin | – | 15.2% |
| Net Margin | – | 4.7% |
| EBT Margin | – | 5.2% |
| Tax Rate | 0.0% | 9.4% |
Financial Health
| Metric | ANRO | COLL |
|---|---|---|
| Current Ratio | 14.85x | 1.01x |
| Quick Ratio | – | 0.87x |
| D/E Ratio | 0.16x | 6.07x |
| Financial Leverage | 1.16x | 7.07x |
| Interest Coverage | -87.2x | 1.1x |
| Working Capital | $231M | $9M |
Cash Flow
| Metric | ANRO | COLL |
|---|---|---|
| Operating Cash Flow | -$68M | $338M |
| Free Cash Flow | -$69M | $336M |
| Capital Spending | -$560K | -$2M |
| OCF Growth YoY | – | 16.2% |
| FCF Growth YoY | – | 16.2% |
| FCF/Sales | – | 41.2% |
| CapEx/Sales | – | 0.2% |
Operational Efficiency
| Metric | ANRO | COLL |
|---|---|---|
| Asset Turnover | – | 0.39x |
| Receivables Turnover | – | 2.6x |
| Inventory Turnover | – | 3.8x |
| Fixed Assets Turnover | – | 75.0x |
| Days Sales Outstanding | – | 139 days |
| Days Inventory | – | 96 days |
| Payables Period | – | 11 days |
| Cash Conversion Cycle | – | 224 days |
Income Statement
| Metric | ANRO | COLL |
|---|---|---|
| Total Revenue | – | $815M |
| Operating Income | -$88M | $124M |
| Net Income | -$84M | $38M |
| R&D Expense | $65M | – |
| SG&A Expense | – | $360M |
| Cost of Goods Sold | – | $334M |
Dividend & Shareholder Information
| Metric | ANRO | COLL |
|---|---|---|
| Shares Outstanding | 39M | 33M |
| Net Income Growth | – | -34.7% |
| EPS Growth | – | -22.0% |
ANRO vs COLL: stock comparison and AI forecast
Which is bigger, ANRO or COLL?
ANRO and COLL have similar market capitalizations ($858M and $819M).
Which stock performed better over the last six months, ANRO or COLL?
Over the last six months ANRO returned -9.1% and COLL -36.0%.
Which one does Intratio's AI model rank higher, ANRO or COLL?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.